Phio pharmaceuticals fintel

Author: mowa

August undefined, 2024

Webb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100... WebbPHIO / Phio Pharmaceuticals Corp off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in …

PHIO: Phio Pharmaceuticals Corp - Stock Price, Quote and News

Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … WebbAt Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against … high vis clip art

PHIO / Phio Pharmaceuticals Corp Implied Volatility - Fintel Labs

WebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] … WebbPhio Pharmaceuticals Our Science Our Science Overview Phio is addressing some of the biggest challenges in immuno-oncology (I/O) by developing therapeutics that leverage … WebbPhio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update. Additional Formats PDF Version. February 22, 2024 Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer. Additional Formats PDF Version. February 13, 2024 ... how many episodes in naruto season 2

PHIO Stock Financial Analysis - Phio Pharmaceuticals Corp

PHIO - Phio Pharmaceuticals Corp. Stock Price and Quote

WebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … Webb6 apr. 2024 · Phio Pharmaceuticals (NASDAQ:PHIO) has a recorded net income of -$11.48 million. PHIO has generated -$10.68 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts … how many episodes in my dear destinyWebb359 rader · Phio Pharmaceuticals Corp insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is … high vis clothing kmart

"WebbPHIO Short Sale Transactions - Phio Pharmaceuticals Corp EXTENDED. Day's Range - 52 Week Range - " - Phio pharmaceuticals fintel

Phio pharmaceuticals fintel

Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration …

Webb12 apr. 2024 · Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on … Webb2024-11-14 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 19 shares of Phio Pharmaceuticals Corp (US:PHIO) with total holdings valued at $0 USD as of 2024 …

Did you know?

WebbFör 1 dag sedan · PHIO PHARMACEUTICALS CORP. : Financial news and information Stock PHIO PHARMACEUTICALS CORP. Nasdaq: PHIO Nasdaq PHIO PHARMACEUTICALS CORP. : Financial news and information Stock PHIO PHARMACEUTICALS CORP. Nasdaq: PHIO Nasdaq PHIO PHARMACEUTICALS CORP. … WebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] Employment opportunities: [email protected] Business development inquiries: [email protected] 257 Simarano Dr Marlborough, MA 01752

Webb7 nov. 2024 · Phio Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024 WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics.

WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in … WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To …

Webb1 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic...

WebbPhio Pharmaceuticals Corp (PHIO) Stock Price Today, News, Quotes, FAQs and Fundamentals 8.50% KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More … high vis clothing detergentWebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of … how many episodes in my sunshineWebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … high vis bomber jacketWebb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … high vis button up long sleeve shirtsWebb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical-stage biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™)... how many episodes in naruto shippuden totalWebbDeutsche Bank Ag\ closes position in PHIO / Phio Pharmaceuticals Corp Institutional Ownership: 13F and NPORT Filings The Security and Class in the table below are shown … high vis clothing osha high vis clothing must be worn